Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor

EGFR-based targeted therapies have shown limited success in smokers. Identification of alternate signaling mechanism(s) leading to TKI resistance in smokers is critically important. We observed increased resistance to erlotinib in H358 NSCLC (non-small cell lung carcinoma) cells chronically exposed...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncoscience 2018-02, Vol.5 (1-2), p.21-38
Hauptverfasser:	Solanki, Hitendra S, Raja, Remya, Zhavoronkov, Alex, Ozerov, Ivan V, Artemov, Artem V, Advani, Jayshree, Radhakrishnan, Aneesha, Babu, Niraj, Puttamallesh, Vinuth N, Syed, Nazia, Nanjappa, Vishalakshi, Subbannayya, Tejaswini, Sahasrabuddhe, Nandini A, Patil, Arun H, Prasad, T S Keshava, Gaykalova, Daria, Chang, Xiaofei, Sathyendran, Rachana, Mathur, Premendu Prakash, Rangarajan, Annapoorni, Sidransky, David, Pandey, Akhilesh, Izumchenko, Evgeny, Gowda, Harsha, Chatterjee, Aditi
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!